Commentary on 'Survival of patients with Pseudomyxoma Peritonei Treated by Serial Debulking'

Colorectal Disease

Volumn 12, Issue 9, 2010, Pages 872-873

  Moran, Brendan J ^a  

^a BASINGSTOKE AND NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOSIS; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; HYPERTHERMIC THERAPY; LAPAROTOMY; MORBIDITY; NOTE; OPERATION DURATION; OUTCOME ASSESSMENT; PERITONEUM PSEUDOMYXOMA; PEROPERATIVE CARE; PRIORITY JOURNAL; REOPERATION; SURGICAL MORTALITY; SURVIVAL TIME;

ADENOCARCINOMA, MUCINOUS; APPENDICEAL NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; HYPERTHERMIA, INDUCED; PALLIATIVE CARE; PERITONEAL NEOPLASMS; PSEUDOMYXOMA PERITONEI; SURVIVAL ANALYSIS;

EID: 77955747468     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2010.02340.x     Document Type: Note

References (5)

1. Sugarbaker PH. Cytoreductive surgery and perioperative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Eur J Surg Oncol 2001, 27:239-43.
2. Moran BJ, Cecil TD. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am 2003, 12(3):585-603.
3. Moran B, Baratti D, Yan TD, Kusamura S, Deraco M. Consensus statement on the loco-regional treatment of appendiceal mucinous neoplams with peritoneal dissemination (pseudomyxoma peritonei). J Surg Oncol 2008, 98:277-82.
4. Smenk RM, van Velthuysen ML, Verwaal VM, Zoetmulder FA. Appendiceal neoplasms and pseudomyxoma peritonei; a population based study. Ann Surg Oncol 2007, 14:493-9.
5. Moran BJ, Meade B, Murphy E. Hyperthermic intraperitoneal chemotherapy and cytoreductive surgery for peritoneal carcinomatosis of colorectal origin: a novel treatment strategy with promising results in selected patients. Colorectal Dis 2006, 8(7):544-50.